Evolt 360 flexes muscles with transformative partnerships in global fitness arena
Health & Biotech
Health & Biotech
Special Report: In the competitive world of health and fitness technology, cutting-edge body composition technology innovator Evolt 360 is fast-tracking its global expansion via significant new partnerships with Goodlife Fitness Canada, Matrix Fitness and Jetts Australia.
GoodLife Fitness Canada is a behemoth of the Canadian fitness scene and the fourth largest globally with 650,000 members across 200 clubs and a team of over 13,000 associates.
Under a new supplier agreement, Evolt 360 is set to play a pivotal role in enhancing GoodLife’s offering with its innovative body composition monitoring technology to be used as a personal training assessment tool to inform customised training plans for GoodLife members.
Evolt has also inked a distribution partnership with Matrix Fitness, a global leader in commercial fitness products and innovative technology solutions.
This collaboration is poised to expand the reach of Evolt 360’s technology, ensuring that fitness enthusiasts and professionals worldwide can harness the power of advanced body composition analysis tools.
Additionally, Evolt 360 has secured its position as a preferred supplier with Aussie heavyweight Jetts, which has a network of more than 200 gyms and over 200,000 members across Australia.
Jetts was the first gym chain in Australia to introduce the 24/7 access model.
Evolt 360 co-founder and CEO Ed Zouroudis says the agreements mark a significant chapter in Evolt 360’s journey.
“We are thrilled to join forces with Matrix Fitness, GoodLife Fitness Canada, and Jetts Australia, who are all significant leaders in the fitness industry,” he said.
“Together, we will empower individuals on their health and fitness journeys and drive innovation in the world of health monitoring technology.”
At the heart of Evolt 360’s success is its medically graded body composition analysis machines, boasting US Food & Drug Administration (FDA) registration, inclusion in the Australian Register of Therapeutic Goods, and Europe’s CE approval.
These machines utilise bioimpedance technology to provide comprehensive insights into body composition health. Users receive data on critical metrics such as skeletal muscle mass, subcutaneous fat, visceral fat, and segmental analysis.
Importantly, these insights empower individuals to pinpoint imbalances and optimise their health and fitness goals through detailed health reports.
The reports are efficiently uploaded to the cloud via Evolt 360’s analytical reporting dashboard, with easy accessibility for users through the EVOLT Active App.
The body composition scanning technology market is predicted to witness huge growth between now and 2030, fuelled by increasing obesity rates.
The global market was worth about $US624m last year and is projected to reach potentially as much as US$1.2 billion by 2030, with market watchers anticipating compound annual growth rates (CAGR) of between 6.4% and 8.9% over that time.
The market for bioimpedance analysers in particular is expected to grow at a CAGR of 10.2% to reach $US471m by 2030.
The fastest growing market is the Asia Pacific, while the largest market is North America.
The company’s partners include major gym chains like Anytime Fitness, 24 Hour Fitness, World Gym, Exponential Fitness, and Virgin Active.
Evolt 360 has also forged meaningful partnerships with corporate giants like health insurer HCF and prestigious international medical universities and allied health professionals.
The new partnerships with Goodlife, Matrix and Jetts represent a significant step towards making the company’s technology more accessible to fitness enthusiasts and professionals, not only in Australia but also on the global stage.
Co-founder Kelly Weideman says Evolt 360’s mission has always been to provide individuals with the tools and insights they need to achieve their health and fitness goals.
“With these ground-breaking agreements, we are one step closer to fulfilling that mission on a global scale.”
This article was developed in collaboration with Evolt 360, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.